Savara Inc Earnings Per Share (Basic)
Savara Inc (SVRA) reported Earnings Per Share (Basic) of -$0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Savara Inc earnings per share, basic for the quarter ending 2026-06-30 was -$0.16.
- Savara Inc earnings per share, basic for the quarter ending 2026-03-31 was -$0.15.
- Savara Inc earnings per share, basic for the quarter ending 2025-12-31 was -$0.13.
- Savara Inc earnings per share, basic for the quarter ending 2025-09-30 was -$0.14.
- Savara Inc earnings per share, basic for fiscal 2025 was -$0.53.
- Savara Inc earnings per share, basic for fiscal 2024 was -$0.48.
- Savara Inc earnings per share, basic for fiscal 2023 was -$0.33.
- Savara Inc earnings per share, basic for fiscal 2022 was -$0.25.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.16 10-Q · filed 2026-08-11 | -$0.31 10-Q · filed 2026-08-11 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-08-11 | |
| 2026-03-31 | -$0.15 10-Q · filed 2026-05-12 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-08-11 | |
| 2025-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.53 10-K · filed 2026-03-13 | |
| 2025-09-30 | -$0.14 10-Q · filed 2025-11-12 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.40 10-Q · filed 2025-11-12 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-08-11 | |
| 2025-06-30 | -$0.14 10-Q · filed 2026-08-11 | -$0.26 10-Q · filed 2026-08-11 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-08-11 | |
| 2025-03-31 | -$0.12 10-Q · filed 2026-05-12 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-05-12 | |
| 2024-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$0.48 10-K · filed 2026-03-13 | |
| 2024-09-30 | -$0.11 10-Q · filed 2025-11-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.35 10-Q · filed 2025-11-12 | -$0.43 derived: net income ÷ weighted average shares · filed 2025-11-12 | |
| 2024-06-30 | -$0.12 10-Q · filed 2025-08-13 | -$0.23 10-Q · filed 2025-08-13 | -$0.31 derived: net income ÷ weighted average shares · filed 2025-08-13 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-08-13 | |
| 2024-03-31 | -$0.11 10-Q · filed 2025-05-13 | -$0.19 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$0.28 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$0.36 derived: net income ÷ weighted average shares · filed 2025-05-13 | |
| 2023-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.17 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.25 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.33 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$0.10 10-Q · filed 2024-11-12 | -$0.17 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.25 10-Q · filed 2024-11-12 | -$0.24 10-Q · filed 2023-11-09 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.07 10-Q · filed 2024-08-12 | -$0.14 10-Q · filed 2024-08-12 | -$0.21 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$0.28 derived: net income ÷ weighted average shares · filed 2024-08-12 | |
| 2023-03-31 | -$0.07 10-Q · filed 2024-05-09 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$0.26 derived: net income ÷ weighted average shares · filed 2024-05-09 | |
| 2022-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$0.25 10-K · filed 2024-03-07 | |
| 2022-09-30 | -$0.07 10-Q · filed 2023-11-09 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.18 10-Q · filed 2023-11-09 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-11-09 | |
| 2022-06-30 | -$0.06 10-Q · filed 2023-08-10 | -$0.11 10-Q · filed 2023-08-10 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-08-10 | |
| 2022-03-31 | -$0.05 10-Q · filed 2023-05-15 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$0.27 derived: net income ÷ weighted average shares · filed 2023-05-15 | |
| 2021-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.14 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.21 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.32 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$0.07 10-Q · filed 2022-11-10 | -$0.14 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.25 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.07 10-Q · filed 2022-08-11 | -$0.18 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |